All relevant data are within the paper, its supporting information files, and its references. These data are available from the study authors, who may be contacted at <shrime@mail.harvard.edu>.

Introduction {#sec005}
============

Health and financial hardship are inextricably linked. Poverty can be both a barrier to healthcare \[[@pone.0168867.ref001]\] and its result, especially in low- and middle-income countries (LMICs), where catastrophic spending on health is common \[[@pone.0168867.ref001]--[@pone.0168867.ref004]\]. For cancer patients, this financial burden also drives poor health outcomes. In Nigeria, for example, one-fifth of children presenting with a rapidly lethal tumor did not get treatment because of cost \[[@pone.0168867.ref005]\].

Unfortunately, improving health and alleviating impoverishment do not always align. Policies that alleviate medically-related financial burden have shown only minimal impacts on health \[[@pone.0168867.ref001], [@pone.0168867.ref006]\]. On the other hand, increasing the number of healthcare providers may, by inducing demand for services with significant costs, counterintuitively increase the risk of financial catastrophe. \[[@pone.0168867.ref001]\]

In Uganda, an East African country of 37·5 million people, \[[@pone.0168867.ref007]\] cancer causes an estimated 11,000 deaths and a loss of 350,000 disability adjusted life years annually. \[[@pone.0168867.ref008]\] As of 2010, only 15% of districts met the Ministry of Health's minimum standards for staffing, and only 11% of the population lived within 5km of any hospital. \[[@pone.0168867.ref009]\] In addition, despite an official abolition of medical user fees in 2001, nearly half of healthcare financing comes from out-of-pocket expenditure, \[[@pone.0168867.ref009]\] putting patients at risk for financial hardship.

Although the treatment of cancer itself is complex and multimodal, surgery is involved in 60% of oncologic disease. \[[@pone.0168867.ref008]\] In LMICs, however, the absence of multimodal therapy often consigns cancer patients to a complete lack of treatment, even when surgery is available. \[[@pone.0168867.ref010]\] Compounding this issue is the fact that the surgical capacity of many first-level hospitals in LMICs tends to be devoted to the treatment of low-burden surgical conditions, leaving patients with more serious surgical conditions like cancer without treatment. \[[@pone.0168867.ref011]\] In Uganda, only 221 surgeons or anaesthesiologists serve the entire 236,000-km^2^ country,\[[@pone.0168867.ref012]\] and medical trainees tend to avoid careers in surgery because of perceived excessive workloads, the risk of contracting HIV, low financial returns, and a poor learning environment.\[[@pone.0168867.ref013]\]

Simultaneously, a large and rapidly growing charitable sector has set itself up as a parallel, fragmented surgical delivery system in many LMICs.\[[@pone.0168867.ref014], [@pone.0168867.ref015]\] These charities, some of which perform cancer surgery, operate under three basic delivery models: short-term surgical trips, self-contained mobile surgical units, and free-standing specialized surgical hospitals.\[[@pone.0168867.ref016]\] Despite a stated preference by patients in at least some LMICs for government health services,\[[@pone.0168867.ref017]\] up to 20% of healthcare and 55% of surgery may be provided by the charitable sector.\[[@pone.0168867.ref018]--[@pone.0168867.ref020]\]

The ability, then, to address equitably the overlapping issues of health and impoverishment intrinsic to medical care will require a holistic evaluation of an entire health system, accounting for the various barriers to care mentioned above---distance, cost, poverty---and the multiple governmental and non-governmental platforms involved. To date, however, no such evaluation has been undertaken. Agent-based simulation modeling, discussed below, is well suited to encompass the various barriers, platforms, and outcomes of interest in a health system, and will be used here.

The goal of this paper, then, is to compare charitable surgical platforms with governmental policies for surgical oncology in Uganda. The hypothesis is that, when the domains of health, impoverishment, and equity are simultaneously considered, charitable platforms will perform as well as, if not better than, many government policies.

Methods {#sec006}
=======

This paper follows a simulated cohort of patients through 50 years in the Ugandan public healthcare system. Details on model construction are given in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}; a brief summary follows.

Platforms examined {#sec007}
------------------

Nine policies and platforms for surgical oncology delivery in Uganda, chosen for their relative frequency of use in LMICs,\[[@pone.0168867.ref021]--[@pone.0168867.ref025]\] are examined. Six governmental policies focus on public sector hospitals:

1.  UPF: Universal public financing, which makes surgery free at the point of care, but does not pay for non-medical costs necessary to seek care

2.  TS: Task shifting of surgery to non-surgeon providers,\[[@pone.0168867.ref026]\] which increases the supply of surgical providers but does not address costs

3.  UPFTS---in which non-surgeon providers are trained in surgery, and the medical costs of care are free to the user

4.  Combinations of each of the above with vouchers to pay for non-medical costs such as transportation (UPF^V^, TS^V^, and UPFTS^V^)\[[@pone.0168867.ref027]\]

On the non-governmental organization (NGO) side, three charitable platforms are examined:\[[@pone.0168867.ref016]\]

7.  Two-week surgical "mission trips" (2W)

8.  Self-contained mobile surgical units (MS)

9.  Free-standing cancer hospitals (CH)

Data from private-sector hospitals in Uganda are unavailable.

Model design {#sec008}
------------

Agent-based models have been proposed as instructive representations of human-human interaction \[[@pone.0168867.ref028]--[@pone.0168867.ref030]\] because they allow the modeler to place patients and providers within physical space and to model their interpersonal networks explicitly.\[[@pone.0168867.ref031]\] By design, these models are stochastic, facilitating the incorporation of uncertainty (around, for example, estimates of cost and mortality). They also relax the assumption, made in prior policy analyses,\[[@pone.0168867.ref001], [@pone.0168867.ref032]--[@pone.0168867.ref034]\] that individuals are independent of each other---a feature necessary for the measurement of impoverishment (as defined below).

A synthetic, open-cohort population of 10,000 individuals was constructed. At instantiation, the cohort mirrored the demographic and socioeconomic profile of the Uganda 2011 Demographic and Health Survey.\[[@pone.0168867.ref035]\] The population was stochastically geopositioned onto a map of Uganda, using GPS data,\[[@pone.0168867.ref036]\] and was connected into family-level and distance-based networks.\[[@pone.0168867.ref028], [@pone.0168867.ref029]\] Population growth parameters were modeled using published background mortality and fertility rates.\[[@pone.0168867.ref037]\] Individual income was drawn from a gamma distribution, parameterized for Uganda.\[[@pone.0168867.ref007], [@pone.0168867.ref038]\] The national poverty line was defined as the income below which 19·5% of the population lived, to match Uganda's poverty headcount.\[[@pone.0168867.ref007]\] Model parameterization is given in **Table A** in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.

The seven most common cancers in Uganda were evaluated in the model (**Table B**, [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}). Modeled incidence was based on published country-specific 2012 data.\[[@pone.0168867.ref039], [@pone.0168867.ref040]\] When an individual became sick, he or she chose whether or not, and where, to seek care, based on a Ugandan multivariate nested logit model of patient and healthcare provider characteristics.\[[@pone.0168867.ref030], [@pone.0168867.ref041], [@pone.0168867.ref042]\] Untreated individuals faced mortality from untreated cancer,\[[@pone.0168867.ref043]--[@pone.0168867.ref045]\] while treated individuals faced mortality and complication rates conditional on the type of provider chosen.

The network of 53 public Ugandan hospitals was also geolocalized.\[[@pone.0168867.ref012]\] Hospital quality metrics were derived from previously published data on surgical delivery in Uganda.\[[@pone.0168867.ref012]\] The NGO platforms were modeled as follows: Because short-term mission trips operate within pre-existing structures,\[[@pone.0168867.ref016]\] 2W was modeled as semi-annual, two-week-long trips to one of the regional referral hospitals. MS was modeled after CinterAndes, a truck-based surgical delivery system in Ecuador.\[[@pone.0168867.ref046]\] CH was modeled as an NGO-run cancer hospital in Mbarara, where a cancer hospital has been proposed. Reported costs for the reference NGOs were divided by the reported numbers of cases performed by each NGO to determine a cost per case. The full code of the model is made available in [S2 Appendix](#pone.0168867.s002){ref-type="supplementary-material"}.

The model cycled daily for 50 years. One hundred runs of the model were performed, each randomly drawing a different parameter set from the parameter distributions shown in **Table A,** [S2 Appendix](#pone.0168867.s002){ref-type="supplementary-material"}. Accounting for births and deaths, this produced on average 2·7 trillion person-years of data for comparison.

Outcome definitions, model validation, and sensitivity analyses {#sec009}
---------------------------------------------------------------

The Ugandan status quo was modeled first; each policy's results represent incremental outcomes against this status quo. Health benefit was measured as the number of cancer deaths averted by an intervention. Catastrophic expenditure was defined as any expenditure that was more than 10% of income prior to the cancer-related illness.\[[@pone.0168867.ref047]--[@pone.0168867.ref049]\]

Because catastrophic expenditure only captures the financial burden incurred by people actually getting care, a second metric---"impoverishment"---was defined to capture the financial burden of a lack of access to care. People were said to be impoverished if a health expense pushed an individual below the national poverty line \[[@pone.0168867.ref007]\], *or* if the head of a household succumbed to cancer---in this case, the remaining family members were counted. This construction was tested in sensitivity analyses.

To measure the distribution of benefits, an "equity index" was constructed for each of the three outcomes (deaths, catastrophic expenditure, and impoverishment), analogous to a Gini coefficient.\[[@pone.0168867.ref050]\] Details on its construction are given in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.

In the base case, the model takes societal perspective, with outcomes reported as yearly averages per 100,000 individuals. Efficiency was defined according to the principles of cost-effectiveness analysis and data envelopment analysis,\[[@pone.0168867.ref051]\] whereby programs that achieve inferior outcomes at equal or higher cost than other program options are said to be inefficient, or "dominated".

Validation was performed against the following known metrics, which were not directly input into the model: predicted population density, predicted 2050 national population, overall cancer incidence, and cancer incidence:mortality ratio. Utilization was also validated by location and by wealth quintile. Details of the validation are given in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.

In addition to the evaluation of heterogeneity and parameter uncertainty, the following sensitivity and scenario analyses were performed:

-   Results presented from the perspective of the Ministry of Health,

-   Results presented as discounted aggregate streams, instead of yearly averages,

-   An increase in the cost of MS by twelve fold, to match the United States IRS Form 990-reported expenses of other mobile NGOs, and

-   A more conservative definition of the "impoverishment" metric, in which impoverishment was counted only if the loss of income from a family member who succumbed to cancer pushed the entire family below a synthetic familial poverty line.

The model was constructed in Java, using the AnyLogic modeling platform (The AnyLogic Company, St. Petersburg, Russia); data analysis was performed in R v3·0 ([www.r-project.org](http://www.r-project.org/)). Because publicly available data were used, ethics approval was not necessary.

Results {#sec010}
=======

Validation and summary results {#sec011}
------------------------------

The model proved to be representative of the population of Uganda. An example validation result is given in **[Fig 1](#pone.0168867.g001){ref-type="fig"}** with further validation in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}. Health and financial risk protection results are given in **[Table 1](#pone.0168867.t001){ref-type="table"}**. Incremental cost-effectiveness ratios for each outcome (deaths, catastrophic expenditure, and impoverishment) are given in **[Table 2](#pone.0168867.t002){ref-type="table"}**. Acceptability curves, displaying the effects of uncertainty across 100 randomly chosen parameter sets, are given in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.

![Population density validation.\
Actual\[[@pone.0168867.ref052]\] vs. modeled population density in Uganda. In the model, each red and blue dot represents one person.](pone.0168867.g001){#pone.0168867.g001}

10.1371/journal.pone.0168867.t001

###### Incremental outcomes, compared against the status quo.

![](pone.0168867.t001){#pone.0168867.t001g}

                                                                                  Platforms and Policies                                                                                                                                                                                                                                                                                                                                                    
  ------------------------------------------------------------------ ------------ ---------------------------------------------- ------------- -------------------------------------------------- ------------------------------------------------- -------------------------------------------------- ----------------------------------------------- -------------------------------------------------- ------------------------------------------------- -----------------------------------------------
  System cost/100,000 people                                                      \$3,320[\*](#t001fn003){ref-type="table-fn"}   \$301         \$3,670[\*](#t001fn003){ref-type="table-fn"}       \$24,470[\*](#t001fn003){ref-type="table-fn"}     \$13,701[\*](#t001fn003){ref-type="table-fn"}      \$25,009[\*](#t001fn003){ref-type="table-fn"}   \$40,438[\*](#t001fn003){ref-type="table-fn"}      \$7,047[\*](#t001fn003){ref-type="table-fn"}      \$54,431[\*](#t001fn003){ref-type="table-fn"}
  Cancer Deaths Averted / 100,000 people                             Poorest      4·9                                            -3·7          4·7                                                51·2[\*](#t001fn003){ref-type="table-fn"}         30·0                                               51·8[\*](#t001fn003){ref-type="table-fn"}       2·4                                                68·2[\*](#t001fn003){ref-type="table-fn"}         35·8
  Poor                                                               5·7          7·1                                            14·0          29·7                                               27·9                                              34·5[\*](#t001fn003){ref-type="table-fn"}          2·6                                             42·2[\*](#t001fn003){ref-type="table-fn"}          27·9                                              
  Middle                                                             1·5          4·6                                            11·2          26·5                                               17·3                                              30·1[\*](#t001fn003){ref-type="table-fn"}          -0·1                                            36·9[\*](#t001fn003){ref-type="table-fn"}          30·3                                              
  Rich                                                               2·9          6·9                                            8·7           23·7                                               13·4                                              27·1                                               1·9                                             35·2[\*](#t001fn003){ref-type="table-fn"}          32·2[\*](#t001fn003){ref-type="table-fn"}         
  Richest                                                            -0·1         1·1                                            5·1           22·6                                               4·6                                               24·5                                               0·6                                             31·6[\*](#t001fn003){ref-type="table-fn"}          25·2                                              
  ***Overall***                                                      ***3·0***    ***3·2***                                      ***8·7***     ***30·7***[\*](#t001fn003){ref-type="table-fn"}    ***18·7***[\*](#t001fn003){ref-type="table-fn"}   ***33·6***[\*](#t001fn003){ref-type="table-fn"}    ***1·5***                                       ***42·8***[\*](#t001fn003){ref-type="table-fn"}    ***30·3***[\*](#t001fn003){ref-type="table-fn"}   
  Catastrophic Expenditure Averted / 100,000 people                  Poorest      -22·7                                          -29·3         -57·7                                              147·7[\*](#t001fn003){ref-type="table-fn"}        -95·5                                              147·7[\*](#t001fn003){ref-type="table-fn"}      7·5                                                87·6                                              59·3
  Poor                                                               -13·7        -40·7                                          -53·9         194·9[\*](#t001fn003){ref-type="table-fn"}         -31·7                                             194·9[\*](#t001fn003){ref-type="table-fn"}         10·1                                            102·9                                              77·8                                              
  Middle                                                             -2·0         -45·3                                          -41·5         226·0[\*](#t001fn003){ref-type="table-fn"}         58·1                                              226·0[\*](#t001fn003){ref-type="table-fn"}         1·6                                             106·5[\*](#t001fn003){ref-type="table-fn"}         89·2                                              
  Rich                                                               16·9         -46·5                                          -4·5          260·8[\*](#t001fn003){ref-type="table-fn"}         151·6[\*](#t001fn003){ref-type="table-fn"}        260·8[\*](#t001fn003){ref-type="table-fn"}         10·8                                            112·2                                              104·8                                             
  Richest                                                            42·7         -12·0                                          41·9          263·8[\*](#t001fn003){ref-type="table-fn"}         202·7[\*](#t001fn003){ref-type="table-fn"}        263·8[\*](#t001fn003){ref-type="table-fn"}         6·1                                             87·9                                               75·1                                              
  ***Overall***                                                      ***4·2***    ***-34·8***                                    ***-23·1***   ***218·6***[\*](#t001fn003){ref-type="table-fn"}   ***57·1***                                        ***218·6***[\*](#t001fn003){ref-type="table-fn"}   ***7·2***                                       ***99·4***[\*](#t001fn003){ref-type="table-fn"}    ***81·2***[\*](#t001fn003){ref-type="table-fn"}   
  Impoverishment Averted / 100,000 people                            Poorest      -12·6                                          -76·3         -79·0                                              516·7[\*](#t001fn003){ref-type="table-fn"}        -19·0                                              518·6[\*](#t001fn003){ref-type="table-fn"}      12·8                                               321·2[\*](#t001fn003){ref-type="table-fn"}        214·9[\*](#t001fn003){ref-type="table-fn"}
  Poor                                                               10·2         13·9                                           24·3          34·7                                               53·0                                              43·5                                               -0·3                                            63·0                                               43·1                                              
  Middle                                                             3·3          6·1                                            19·0          35·5                                               33·2                                              36·6                                               0·4                                             57·1                                               47·4                                              
  Rich                                                               5·5          16·2                                           16·6          21·4                                               22·8                                              28·3                                               1·5                                             53·7                                               45·0                                              
  Richest                                                            -2·9         -0·7                                           10·2          10·7                                               -0·2                                              9·0                                                -2·5                                            38·2                                               24·0                                              
  ***Overall***                                                      ***0·7***    ***-8·1***                                     ***-1·8***    ***123·8***[\*](#t001fn003){ref-type="table-fn"}   ***18·0***                                        ***127·2***[\*](#t001fn003){ref-type="table-fn"}   ***2·4***                                       ***106·6***[\*](#t001fn003){ref-type="table-fn"}   ***74·9***[\*](#t001fn003){ref-type="table-fn"}   
  Treatment probability, given a cancer diagnosis                    Poorest      5·4                                            4·9           11·9                                               39·1[\*](#t001fn003){ref-type="table-fn"}         27·6[\*](#t001fn003){ref-type="table-fn"}          46·5[\*](#t001fn003){ref-type="table-fn"}       1·1                                                24·2[\*](#t001fn003){ref-type="table-fn"}         9·9
  Poor                                                               5·0          6·6                                            12·0          32·4[\*](#t001fn003){ref-type="table-fn"}          24·8[\*](#t001fn003){ref-type="table-fn"}         40·4[\*](#t001fn003){ref-type="table-fn"}          0·9                                             20·0[\*](#t001fn003){ref-type="table-fn"}          12·0                                              
  Middle                                                             3·6          7·4                                            11·6          27·7[\*](#t001fn003){ref-type="table-fn"}          22·2[\*](#t001fn003){ref-type="table-fn"}         34·5[\*](#t001fn003){ref-type="table-fn"}          1·2                                             17·2[\*](#t001fn003){ref-type="table-fn"}          14·1                                              
  Rich                                                               3·0          6·6                                            10·1          22·5[\*](#t001fn003){ref-type="table-fn"}          17·5[\*](#t001fn003){ref-type="table-fn"}         28·3[\*](#t001fn003){ref-type="table-fn"}          0·3                                             14·1                                               13·4                                              
  Richest                                                            1·9          5·9                                            7·9           19·7[\*](#t001fn003){ref-type="table-fn"}          12·9                                              25·5[\*](#t001fn003){ref-type="table-fn"}          1·1                                             13·5                                               12·2                                              
  ***Overall***                                                      ***3·8***    ***6·3***                                      ***10·7***    ***28·3***[\*](#t001fn003){ref-type="table-fn"}    ***21·0***[\*](#t001fn003){ref-type="table-fn"}   ***35·0***[\*](#t001fn003){ref-type="table-fn"}    ***0·9***                                       ***17·8***[\*](#t001fn003){ref-type="table-fn"}    ***12·3***[\*](#t001fn003){ref-type="table-fn"}   
  Incidence: Mortality ratio[^a^](#t001fn003){ref-type="table-fn"}   Poorest      1·03                                           0·98          1·04                                               1·35[\*](#t001fn003){ref-type="table-fn"}         1·18[\*](#t001fn003){ref-type="table-fn"}          1·35[\*](#t001fn003){ref-type="table-fn"}       1·02                                               1·57[\*](#t001fn003){ref-type="table-fn"}         1·24[\*](#t001fn003){ref-type="table-fn"}
  Poor                                                               1·06         1·06                                           1·12          1·29[\*](#t001fn003){ref-type="table-fn"}          1·25[\*](#t001fn003){ref-type="table-fn"}         1·39[\*](#t001fn003){ref-type="table-fn"}          1·01                                            1·46[\*](#t001fn003){ref-type="table-fn"}          1·27[\*](#t001fn003){ref-type="table-fn"}         
  Middle                                                             1·03         1·06                                           1·10          1·31[\*](#t001fn003){ref-type="table-fn"}          1·16                                              1·37[\*](#t001fn003){ref-type="table-fn"}          1·02                                            1·45[\*](#t001fn003){ref-type="table-fn"}          1·36[\*](#t001fn003){ref-type="table-fn"}         
  Rich                                                               1·02         1·06                                           1·08          1·28[\*](#t001fn003){ref-type="table-fn"}          1·12                                              1·33[\*](#t001fn003){ref-type="table-fn"}          1·02                                            1·43[\*](#t001fn003){ref-type="table-fn"}          1·35[\*](#t001fn003){ref-type="table-fn"}         
  Richest                                                            1·00         1·02                                           1·05          1·30[\*](#t001fn003){ref-type="table-fn"}          1·05                                              1·34[\*](#t001fn003){ref-type="table-fn"}          1·03                                            1·44[\*](#t001fn003){ref-type="table-fn"}          1·34[\*](#t001fn003){ref-type="table-fn"}         
  ***Overall***                                                      ***1·03***   ***1·04***                                     ***1·08***    ***1·30***[\*](#t001fn003){ref-type="table-fn"}    ***1·15***[\*](#t001fn003){ref-type="table-fn"}   ***1·35***[\*](#t001fn003){ref-type="table-fn"}    ***1·02***                                      ***1·46***[\*](#t001fn003){ref-type="table-fn"}    ***1·32***[\*](#t001fn003){ref-type="table-fn"}   

Incremental results over the status quo, per 100,000 in the population, on average, per year; positive numbers indicate improvement over the status quo.

^a^Relative improvement: numbers \>1·0 indicate an improvement over the status quo. UPF = universal public financing, TS = task shifting, V = vouchers, 2W = two-week mission trip, MS = mobile surgical platform, CH = cancer hospital.

\* = *p* \< 0·05.

10.1371/journal.pone.0168867.t002

###### Incremental cost-effectiveness ratios.

![](pone.0168867.t002){#pone.0168867.t002g}

                                               Incremental cost-effectiveness ratios              
  -------------------------------- ----------- --------------------------------------- ---------- ---------
  Governmental policies            TS          \$88·65                                 *---*      *---*
  UPF^V^                           ---         \$111·88                                *---*      
  UPFTS                            \$631·41    *---*                                   *---*      
  UPFTS^V^                         \$662·35    *---*                                   \$197·06   
  Non-governmental organizations   MS          \$154·78                                \$66·34    \$62·02
  All policies and platforms       TS          \$88·65                                 *---*      *---*
  MS                               \$160·29    \$66·34                                 \$62·02    
  UPF^V^                           *---*       \$150·48                                *---*      
  UPFTS^V^                         \$6022·33   *---*                                   \$897·31   

Incremental cost-effectiveness ratios (ICERs) for governmental policies, non-governmental platforms, and both, in dollars per case averted. A long dash signifies that the policy is dominated by other policies for that outcome---that is, that other policies deliver more benefit at a lower cost. Strategies dominated in all three columns are not shown. TS = task shifting, UPF = universal public finance, V = vouchers, MS = mobile surgical unit, CH = cancer hospital.

Efficiency frontiers {#sec012}
--------------------

Efficiency frontiers plot benefit against cost. On these graphs, policies to the upper-left provide the most benefit for the lowest cost. (A more detailed explanation is given in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}).

If a decision-maker is willing to consider both governmental and NGO policies, only MS is efficient at averting deaths while simultaneously preventing catastrophic expenditure and impoverishment. The incremental cost per death averted is \$160 (or, approximately 25% of Uganda's GDP/capita), while the cost per case of catastrophic expenditure or impoverishment averted is each approximately \$60.

Other policies can deliver isolated benefits efficiently: TS and UPFTS^V^ efficiently prevent cancer deaths; UPF^V^ efficiently prevents catastrophic expenditure; and UPFTS^V^ efficiently prevents impoverishment (**[Fig 2](#pone.0168867.g002){ref-type="fig"}**).

![Efficiency frontiers for all policies and platforms.\
Incremental cost-effectiveness ratios are given in [Table 2](#pone.0168867.t002){ref-type="table"}. A) Deaths averted per 100,000 people. B) Catastrophic expenditure averted per 100,000 people. C) Impoverishment averted per 100,000 people. UPF = universal public finance. TS = task shifting. V = vouchers. MS = mobile surgical unit. CH = cancer hospital. 2W = two-week surgical mission. The interpretation of efficiency frontiers is explained in detail in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.](pone.0168867.g002){#pone.0168867.g002}

Intrasectoral comparisons (ie, NGOs alone or government policies alone) are given in **[Table 2](#pone.0168867.t002){ref-type="table"}** and in **Figs I** and **J** in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.

Standardized outcomes {#sec013}
---------------------

To aid in decision-making across health and financial domains, **[Fig 3](#pone.0168867.g003){ref-type="fig"}** standardizes outcomes against the cost of each policy.\[[@pone.0168867.ref053]\] Policies toward the right are the most efficient at delivering health per dollar, with those in the upper right delivering the most health *and* financial benefits per dollar. In this formulation, both TS and MS are efficient.

![Health and financial risk protection per \$100,000 spent.\
Policies closest to the upper right are most efficient. A) Deaths averted vs. catastrophic expenditure averted. B) Deaths averted vs. impoverishment averted. For both financial risk protection outcomes, the mobile surgical unit is dominant. Note that negative cases of catastrophic risk protection and impoverishment averted imply cases *created* by the respective policies. UPF = universal public finance. TS = task shifting. V = vouchers. MS = mobile surgical unit. CH = cancer hospital. 2W = two-week surgical mission. The interpretation of these standardized outcomes panels is explained in detail in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.](pone.0168867.g003){#pone.0168867.g003}

Equity {#sec014}
------

The equitable distribution of health and impoverishment benefits for each of the nine policies and platforms is summarized by the equity index (**[Table 3](#pone.0168867.t003){ref-type="table"}**), in which a more positive value indicates a more pro-poor outcome distribution. All NGO platforms, as well as UPF^V^ and UPFTS^V^, demonstrate a pro-poor distribution. The remaining policies tend to provide benefit preferentially to the more wealthy.

10.1371/journal.pone.0168867.t003

###### Equity.

![](pone.0168867.t003){#pone.0168867.t003g}

                                            Equity index                     
  -------------------------------- -------- -------------- -------- -------- --------
  Governmental policies            UPF      0·332          -0·479   -0·088   -0·079
  TS                               -0·109   -0·196         -0·180   -0·162   
  UPFTS                            0·041    -0·575         -0·177   -0·237   
  UPF^V^                           0·164    -0·109         0·663    0·239    
  TS^V^                            0·280    -0·409         -0·016   -0·048   
  UPFTS^V^                         0·148    -0·109         0·650    0·230    
  Non-governmental organizations   2W       0·203          0·023    0·472    0·233
  MS                               0·150    -0·008         0·432    0·191    
  CH                               0·044    -0·058         0·406    0·131    

Equity index of benefits, measuring how pro-poor an intervention is. The more positive the number, the higher the concentration of the benefits accruing to the poorest patients. CH = cancer hospital, MS = mobile surgical unit, TS = task shifting, UPF = universal public finance, V = vouchers, 2W = two-week surgical "mission trips".

Sensitivity analysis on the cost of mobile surgery {#sec015}
--------------------------------------------------

Mobile surgical platforms vary immensely in cost. To evaluate the sensitivity of the above results to this variability, we increased the unit cost per surgery twelvefold for MS, to match the expenses reported to the United States IRS by other mobile surgical NGOs. With this large increase, MS remained an efficient strategy for saving lives, but became dominated as a strategy to prevent catastrophic expenditure or impoverishment (**[Fig 4](#pone.0168867.g004){ref-type="fig"}**). Other sensitivity analyses are shown in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}.

![Efficiency frontiers when the cost of the mobile surgical unit is increased.\
A) Deaths averted per 100,000 people. B) Catastrophic expenditure averted per 100,000 people. C) Impoverishment averted per 100,000 people. The platform falls off the efficiency frontier for the financial risk protective outcomes.](pone.0168867.g004){#pone.0168867.g004}

Discussion {#sec016}
==========

The Sustainable Development Goals, adopted in September 2015, propose an end to all poverty (Goal 1) while simultaneously ensuring health and wellbeing, equitably for all (Goal 3).\[[@pone.0168867.ref054]\] These goals are intertwined: to create sustainable development, health systems must do more than simply improve health; they must provide financial risk protection and do so equitably.\[[@pone.0168867.ref055]\] However, most policy evaluations to date have focused only on medical incomes, and most policymakers have traditionally looked to the public sector alone to accomplish these aims.\[[@pone.0168867.ref056]\]

Our results indicate that the exclusion of NGO platforms in health system evaluations may be unwarranted.

In the setting of surgical oncology in Uganda, the only governmental policies that were able provide health benefits, protection against impoverishment, and equity were those that simultaneously addressed the lack of surgical supply, the out-of-pocket medical costs of a procedure, *and* the often ignored non-medical costs of transportation. These tend to be very expensive policies. On the other hand, mobile surgical units---of the sorts already in place in other countries\[[@pone.0168867.ref046]\]---can meet sustainable development goals efficiently and equitably.

The dominance of these mobile platforms seems initially counterintuitive---they are, after all, uncommon modalities for healthcare delivery in general, and surgery in specific. However, they address at least two of what have been called the "three delays" in healthcare.\[[@pone.0168867.ref057]\] By decreasing the distance from the patient to the provider, they shorten the "second delay" of getting to care. This decreased distance, combined with the charitable model of low-to-nil out-of-pocket payments,\[[@pone.0168867.ref046]\] also shortens the "first delay" of deciding to seek care in the first place. (The "third delay"---getting care once the provider is reached---is not explicitly examined in this paper.)

Notably, our results do not support the use of very common policies and platforms, such as the isolated removal of user fees. Earlier evidence has been mixed for the health and financial benefits of user fee removal,\[[@pone.0168867.ref058]--[@pone.0168867.ref060]\] despite its relative ease of implementation. Our results indicate that it is dominated---that is, other policies provide more benefit for a lower cost. This conclusion is strengthened by the fact that the UPF policy is evaluated in the best case scenario, when *all* direct medical costs are shifted off the patient. In settings in which residual costs still exist (such as registration fees, informal payments, etc), the results here are overestimates of the actual effects.

Also not supported is the most common charitable platform---the short-term "mission trip."\[[@pone.0168867.ref016]\] These mission trips are more expensive and less effective than almost every other policy or platform, NGO or otherwise. Other evidence has shown that these trips do not deliver good health outcomes;\[[@pone.0168867.ref016]\] our results also suggest that these relatively poor outcomes are delivered at high cost.

Limitations and strengths {#sec017}
-------------------------

This model, like all models, has limitations. First, all models are limited by data. Uganda was chosen because of the higher availability of data compared to other sub-Saharan African contexts, but these data, including the future incidence of cancer, may change and such changes may change our findings. However, the cancer incidence in the country is derived from hospital records, pharmacies, laboratories, and death registries. In addition, the model proved well calibrated to measurable outcomes in Uganda, which, combined with the fact that modeling assumptions introduced to overcome data limitations will underestimate benefits (as discussed in [S1 Appendix](#pone.0168867.s001){ref-type="supplementary-material"}), reinforces the results.

Secondly, although this model supports the role of an NGO platform, it cannot examine the externalities of the NGO sector---brain drain, the establishment of parallel markets, and engendering dependency of countries on external aid.\[[@pone.0168867.ref061]\] It also does not measure the persistence of impoverishment into the future, instead measuring the *incidence* of financial catastrophe, as opposed to its prevalence. Finally, there are potential economies of scale that cannot be elucidated by a model limited to a starting population of 10,000 individauls. These are left for future considerations.

The mobile NGO chosen for analysis is an in-country NGO---staffed by local physicians, run locally, and without a large international presence \[[@pone.0168867.ref046]\]. However, when costs for the mobile NGO are increased to match those of a large international NGO, the platform remains efficient at saving lives, although it loses its financial risk protection efficiency.

Finally, this paper looks at surgical oncology delivered in one country, by a limited bundle of platforms. Because of a lack of available data, the private sector in Uganda had to be excluded, as well as the costs of adjuvant therapy. Generalizability of the results to other contexts must therefore be done with caution, and the policy conclusions must necessarily be viewed as suggestive rather than definitive.

Despite these limitations, this paper, however, accomplishes two things. Methodologically, it presents a novel technique for holistic health system evaluation, able to address multiple barriers to care, platforms of delivery, and domains of outcome simultaneously, with uncertainty incorporated directly into the model, and does so in a way that validates strongly against known population and economic parameters. As such, it overcomes some limitations inherent to prior extended cost-effectiveness analyses,\[[@pone.0168867.ref001], [@pone.0168867.ref032]--[@pone.0168867.ref034]\] on which it is built. Although this paper is obviously limited to surgical oncology in one sub-Saharan African country, the technique developed here can be easily extended to other countries and other conditions.

More importantly, however, the results suggest concrete policy recommendations. If policymakers want to jointly address the sustainable development goals of health, poverty, and equity, mobile surgical units are worth considering. Importantly, although they are examined here as a non-governmental platform, there is no reason that mobile surgical units must remain the purview of the charitable sector. Some countries have already incorporated them into their national surgical delivery plans.\[[@pone.0168867.ref062]\] Mobile surgical units cannot replace full health-system and surgical system strengthening, and should not be considered the answer to the problem of surgical delivery. However, this model suggests that they can be considered along an expansion path toward full surgical scaleup.

Conclusion {#sec018}
==========

In cancer patients, an inability to access the surgical system can be lethal, but accessing it can be impoverishing. This paper demonstrates that mobile surgical units are an efficient and equitable method for improving health and protecting against medical impoverishment. These platforms compare well with comprehensive health-systems-strengthening policies. Short-term surgical mission trips, as well as policies that only remove the out-of-pocket cost for care, appear neither efficient nor equitable.
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